Market Forecast By Product (Neomycin, Tobramycin, Gentamicin, Amikacin, Paromomycin, Streptomycin, Kanamycin, Others), By Route of Administration (Injectables (Parenteral), Feed, Intra-mammary, Topical, Oral), By Application (Veterinary, Skin Infection, Respiratory diseases, UTI & Pelvic Diseases, Other diseases) And Competitive Landscape
Product Code: ETC312084 | Publication Date: Aug 2023 | Updated Date: Apr 2025 | Product Type: Market Research Report | |
Publisher: 6Wresearch | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 | |
The India Aminoglycosides Market is projected to witness mixed growth rate patterns during 2025 to 2029. Growth accelerates to 13.72% in 2028, following an initial rate of 12.53%, before easing to 13.29% at the end of the period.
The India aminoglycosides market is set to witness considerable growth in the coming years. Aminoglycosides are a group of antibiotics widely used for the treatment of bacterial infections. The market`s outlook is driven by the increasing prevalence of infectious diseases and the growing demand for effective antimicrobial drugs. As the healthcare and pharmaceutical sectors continue to grow in India, the demand for aminoglycosides in hospital settings and community healthcare is expected to fuel market growth. Additionally, the development of advanced formulations and dosage forms is likely to further boost the market`s expansion. Market players should focus on offering safe and efficacious aminoglycosides and invest in research and development to combat antibiotic resistance.
The India aminoglycosides market is anticipated to witness steady growth in the coming years. Aminoglycosides are a class of antibiotics used in the treatment of bacterial infections. The growth of the pharmaceutical industry, driven by the increasing incidence of infectious diseases, is a key driver for the market. Additionally, aminoglycosides find applications in veterinary medicine for the treatment of bacterial infections in animals. However, challenges such as the emergence of antibiotic resistance and the availability of alternative antibiotics may impact the market`s growth. Efforts towards developing new aminoglycoside derivatives and combination therapies are expected to drive the adoption of aminoglycosides in the market.
The India aminoglycosides market is witnessing significant growth as aminoglycosides are widely used as antibiotics in the treatment of bacterial infections. This market`s outlook is driven by factors such as the increasing incidence of infectious diseases, the growth of the healthcare and pharmaceutical sectors, and the adoption of aminoglycosides for their broad-spectrum antimicrobial activity. Additionally, the development of novel and modified aminoglycosides and the rising focus on antimicrobial stewardship and drug resistance management are further contributing to market growth. However, the market faces challenges such as the need to address potential side effects and toxicities associated with aminoglycoside usage and the emergence of drug-resistant bacteria.
The India aminoglycosides market is witnessing significant growth as the pharmaceutical and healthcare industries utilize these antibiotics for various therapeutic applications. This market`s outlook is driven by factors such as the increasing demand for aminoglycosides in the treatment of bacterial infections, the growth of the healthcare and life sciences sectors, and the adoption of aminoglycosides for their broad-spectrum activity and effectiveness against resistant strains. Additionally, the development of advanced formulations and dosage forms for aminoglycosides and the rising focus on antimicrobial stewardship and infection control are further contributing to market growth. The market faced some impact during the COVID-19 pandemic due to changes in healthcare priorities and disruptions in supply chain challenges. However, it is expected to recover with the resumption of healthcare services and the growing demand for antibiotics and antimicrobial drugs.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 India Aminoglycosides Market Overview |
3.1 India Country Macro Economic Indicators |
3.2 India Aminoglycosides Market Revenues & Volume, 2021 & 2031F |
3.3 India Aminoglycosides Market - Industry Life Cycle |
3.4 India Aminoglycosides Market - Porter's Five Forces |
3.5 India Aminoglycosides Market Revenues & Volume Share, By Product, 2021 & 2031F |
3.6 India Aminoglycosides Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.7 India Aminoglycosides Market Revenues & Volume Share, By Application, 2021 & 2031F |
4 India Aminoglycosides Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 India Aminoglycosides Market Trends |
6 India Aminoglycosides Market, By Types |
6.1 India Aminoglycosides Market, By Product |
6.1.1 Overview and Analysis |
6.1.2 India Aminoglycosides Market Revenues & Volume, By Product, 2021-2031F |
6.1.3 India Aminoglycosides Market Revenues & Volume, By Neomycin, 2021-2031F |
6.1.4 India Aminoglycosides Market Revenues & Volume, By Tobramycin, 2021-2031F |
6.1.5 India Aminoglycosides Market Revenues & Volume, By Gentamicin, 2021-2031F |
6.1.6 India Aminoglycosides Market Revenues & Volume, By Amikacin, 2021-2031F |
6.1.7 India Aminoglycosides Market Revenues & Volume, By Paromomycin, 2021-2031F |
6.1.8 India Aminoglycosides Market Revenues & Volume, By Streptomycin, 2021-2031F |
6.1.9 India Aminoglycosides Market Revenues & Volume, By Others, 2021-2031F |
6.1.10 India Aminoglycosides Market Revenues & Volume, By Others, 2021-2031F |
6.2 India Aminoglycosides Market, By Route of Administration |
6.2.1 Overview and Analysis |
6.2.2 India Aminoglycosides Market Revenues & Volume, By Injectables (Parenteral), 2021-2031F |
6.2.3 India Aminoglycosides Market Revenues & Volume, By Feed, 2021-2031F |
6.2.4 India Aminoglycosides Market Revenues & Volume, By Intra-mammary, 2021-2031F |
6.2.5 India Aminoglycosides Market Revenues & Volume, By Topical, 2021-2031F |
6.2.6 India Aminoglycosides Market Revenues & Volume, By Oral, 2021-2031F |
6.3 India Aminoglycosides Market, By Application |
6.3.1 Overview and Analysis |
6.3.2 India Aminoglycosides Market Revenues & Volume, By Veterinary, 2021-2031F |
6.3.3 India Aminoglycosides Market Revenues & Volume, By Skin Infection, 2021-2031F |
6.3.4 India Aminoglycosides Market Revenues & Volume, By Respiratory diseases, 2021-2031F |
6.3.5 India Aminoglycosides Market Revenues & Volume, By UTI & Pelvic Diseases, 2021-2031F |
6.3.6 India Aminoglycosides Market Revenues & Volume, By Other diseases, 2021-2031F |
7 India Aminoglycosides Market Import-Export Trade Statistics |
7.1 India Aminoglycosides Market Export to Major Countries |
7.2 India Aminoglycosides Market Imports from Major Countries |
8 India Aminoglycosides Market Key Performance Indicators |
9 India Aminoglycosides Market - Opportunity Assessment |
9.1 India Aminoglycosides Market Opportunity Assessment, By Product, 2021 & 2031F |
9.2 India Aminoglycosides Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.3 India Aminoglycosides Market Opportunity Assessment, By Application, 2021 & 2031F |
10 India Aminoglycosides Market - Competitive Landscape |
10.1 India Aminoglycosides Market Revenue Share, By Companies, 2024 |
10.2 India Aminoglycosides Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |